Global Plasma Fractionation and Blood Product Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 305042
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Plasma Fractionation and Blood Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Plasma Fractionation and Blood Product market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunology accounting for % of the Plasma Fractionation and Blood Product global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Coagulation Factor segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Plasma Fractionation and Blood Product include Takeda, CSL, Grifols, Octapharma, and Kedrion, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Plasma Fractionation and Blood Product market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Coagulation Factor

Immune Globulin

Albumin

Other

Market segment by Application can be divided into

Immunology

Hematology

Other

The key market players for global Plasma Fractionation and Blood Product market are listed below:

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Plasma Fractionation and Blood Product product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Plasma Fractionation and Blood Product, with price, sales, revenue and global market share of Plasma Fractionation and Blood Product from 2019 to 2022.

Chapter 3, the Plasma Fractionation and Blood Product competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Plasma Fractionation and Blood Product breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Plasma Fractionation and Blood Product market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma Fractionation and Blood Product.

Chapter 13, 14, and 15, to describe Plasma Fractionation and Blood Product sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Plasma Fractionation and Blood Product Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Plasma Fractionation and Blood Product Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Coagulation Factor

1.2.3 Immune Globulin

1.2.4 Albumin

1.2.5 Other

1.3 Market Analysis by Application

1.3.1 Overview: Global Plasma Fractionation and Blood Product Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Immunology

1.3.3 Hematology

1.3.4 Other

1.4 Global Plasma Fractionation and Blood Product Market Size & Forecast

1.4.1 Global Plasma Fractionation and Blood Product Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Plasma Fractionation and Blood Product Sales in Volume (2017-2028)

1.4.3 Global Plasma Fractionation and Blood Product Price (2017-2028)

1.5 Global Plasma Fractionation and Blood Product Production Capacity Analysis

1.5.1 Global Plasma Fractionation and Blood Product Total Production Capacity (2017-2028)

1.5.2 Global Plasma Fractionation and Blood Product Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Plasma Fractionation and Blood Product Market Drivers

1.6.2 Plasma Fractionation and Blood Product Market Restraints

1.6.3 Plasma Fractionation and Blood Product Trends Analysis

2 Manufacturers Profiles

2.1 Takeda

2.1.1 Takeda Details

2.1.2 Takeda Major Business

2.1.3 Takeda Plasma Fractionation and Blood Product Product and Services

2.1.4 Takeda Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 CSL

2.2.1 CSL Details

2.2.2 CSL Major Business

2.2.3 CSL Plasma Fractionation and Blood Product Product and Services

2.2.4 CSL Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Grifols

2.3.1 Grifols Details

2.3.2 Grifols Major Business

2.3.3 Grifols Plasma Fractionation and Blood Product Product and Services

2.3.4 Grifols Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Octapharma

2.4.1 Octapharma Details

2.4.2 Octapharma Major Business

2.4.3 Octapharma Plasma Fractionation and Blood Product Product and Services

2.4.4 Octapharma Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Kedrion

2.5.1 Kedrion Details

2.5.2 Kedrion Major Business

2.5.3 Kedrion Plasma Fractionation and Blood Product Product and Services

2.5.4 Kedrion Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 LFB Group

2.6.1 LFB Group Details

2.6.2 LFB Group Major Business

2.6.3 LFB Group Plasma Fractionation and Blood Product Product and Services

2.6.4 LFB Group Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Biotest

2.7.1 Biotest Details

2.7.2 Biotest Major Business

2.7.3 Biotest Plasma Fractionation and Blood Product Product and Services

2.7.4 Biotest Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 BPL

2.8.1 BPL Details

2.8.2 BPL Major Business

2.8.3 BPL Plasma Fractionation and Blood Product Product and Services

2.8.4 BPL Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 RAAS

2.9.1 RAAS Details

2.9.2 RAAS Major Business

2.9.3 RAAS Plasma Fractionation and Blood Product Product and Services

2.9.4 RAAS Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 CBPO

2.10.1 CBPO Details

2.10.2 CBPO Major Business

2.10.3 CBPO Plasma Fractionation and Blood Product Product and Services

2.10.4 CBPO Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 Hualan Bio

2.11.1 Hualan Bio Details

2.11.2 Hualan Bio Major Business

2.11.3 Hualan Bio Plasma Fractionation and Blood Product Product and Services

2.11.4 Hualan Bio Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Plasma Fractionation and Blood Product Breakdown Data by Manufacturer

3.1 Global Plasma Fractionation and Blood Product Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Plasma Fractionation and Blood Product Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Plasma Fractionation and Blood Product

3.4 Market Concentration Rate

3.4.1 Top 3 Plasma Fractionation and Blood Product Manufacturer Market Share in 2021

3.4.2 Top 6 Plasma Fractionation and Blood Product Manufacturer Market Share in 2021

3.5 Global Plasma Fractionation and Blood Product Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Plasma Fractionation and Blood Product Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Plasma Fractionation and Blood Product Market Size by Region

4.1.1 Global Plasma Fractionation and Blood Product Sales in Volume by Region (2017-2028)

4.1.2 Global Plasma Fractionation and Blood Product Revenue by Region (2017-2028)

4.2 North America Plasma Fractionation and Blood Product Revenue (2017-2028)

4.3 Europe Plasma Fractionation and Blood Product Revenue (2017-2028)

4.4 Asia-Pacific Plasma Fractionation and Blood Product Revenue (2017-2028)

4.5 South America Plasma Fractionation and Blood Product Revenue (2017-2028)

4.6 Middle East and Africa Plasma Fractionation and Blood Product Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Plasma Fractionation and Blood Product Sales in Volume by Type (2017-2028)

5.2 Global Plasma Fractionation and Blood Product Revenue by Type (2017-2028)

5.3 Global Plasma Fractionation and Blood Product Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Plasma Fractionation and Blood Product Sales in Volume by Application (2017-2028)

6.2 Global Plasma Fractionation and Blood Product Revenue by Application (2017-2028)

6.3 Global Plasma Fractionation and Blood Product Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Plasma Fractionation and Blood Product Sales by Type (2017-2028)

7.2 North America Plasma Fractionation and Blood Product Sales by Application (2017-2028)

7.3 North America Plasma Fractionation and Blood Product Market Size by Country

7.3.1 North America Plasma Fractionation and Blood Product Sales in Volume by Country (2017-2028)

7.3.2 North America Plasma Fractionation and Blood Product Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Plasma Fractionation and Blood Product Sales by Type (2017-2028)

8.2 Europe Plasma Fractionation and Blood Product Sales by Application (2017-2028)

8.3 Europe Plasma Fractionation and Blood Product Market Size by Country

8.3.1 Europe Plasma Fractionation and Blood Product Sales in Volume by Country (2017-2028)

8.3.2 Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (2017-2028)

9.2 Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (2017-2028)

9.3 Asia-Pacific Plasma Fractionation and Blood Product Market Size by Region

9.3.1 Asia-Pacific Plasma Fractionation and Blood Product Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Plasma Fractionation and Blood Product Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Plasma Fractionation and Blood Product Sales by Type (2017-2028)

10.2 South America Plasma Fractionation and Blood Product Sales by Application (2017-2028)

10.3 South America Plasma Fractionation and Blood Product Market Size by Country

10.3.1 South America Plasma Fractionation and Blood Product Sales in Volume by Country (2017-2028)

10.3.2 South America Plasma Fractionation and Blood Product Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Plasma Fractionation and Blood Product Sales by Type (2017-2028)

11.2 Middle East & Africa Plasma Fractionation and Blood Product Sales by Application (2017-2028)

11.3 Middle East & Africa Plasma Fractionation and Blood Product Market Size by Country

11.3.1 Middle East & Africa Plasma Fractionation and Blood Product Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Plasma Fractionation and Blood Product Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Plasma Fractionation and Blood Product and Key Manufacturers

12.2 Manufacturing Costs Percentage of Plasma Fractionation and Blood Product

12.3 Plasma Fractionation and Blood Product Production Process

12.4 Plasma Fractionation and Blood Product Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Plasma Fractionation and Blood Product Typical Distributors

13.3 Plasma Fractionation and Blood Product Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Plasma Fractionation and Blood Product Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Plasma Fractionation and Blood Product Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Takeda Basic Information, Manufacturing Base and Competitors

Table 4. Takeda Major Business

Table 5. Takeda Plasma Fractionation and Blood Product Product and Services

Table 6. Takeda Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. CSL Basic Information, Manufacturing Base and Competitors

Table 8. CSL Major Business

Table 9. CSL Plasma Fractionation and Blood Product Product and Services

Table 10. CSL Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Grifols Basic Information, Manufacturing Base and Competitors

Table 12. Grifols Major Business

Table 13. Grifols Plasma Fractionation and Blood Product Product and Services

Table 14. Grifols Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Octapharma Basic Information, Manufacturing Base and Competitors

Table 16. Octapharma Major Business

Table 17. Octapharma Plasma Fractionation and Blood Product Product and Services

Table 18. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Kedrion Basic Information, Manufacturing Base and Competitors

Table 20. Kedrion Major Business

Table 21. Kedrion Plasma Fractionation and Blood Product Product and Services

Table 22. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. LFB Group Basic Information, Manufacturing Base and Competitors

Table 24. LFB Group Major Business

Table 25. LFB Group Plasma Fractionation and Blood Product Product and Services

Table 26. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Biotest Basic Information, Manufacturing Base and Competitors

Table 28. Biotest Major Business

Table 29. Biotest Plasma Fractionation and Blood Product Product and Services

Table 30. Biotest Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. BPL Basic Information, Manufacturing Base and Competitors

Table 32. BPL Major Business

Table 33. BPL Plasma Fractionation and Blood Product Product and Services

Table 34. BPL Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. RAAS Basic Information, Manufacturing Base and Competitors

Table 36. RAAS Major Business

Table 37. RAAS Plasma Fractionation and Blood Product Product and Services

Table 38. RAAS Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. CBPO Basic Information, Manufacturing Base and Competitors

Table 40. CBPO Major Business

Table 41. CBPO Plasma Fractionation and Blood Product Product and Services

Table 42. CBPO Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Hualan Bio Basic Information, Manufacturing Base and Competitors

Table 44. Hualan Bio Major Business

Table 45. Hualan Bio Plasma Fractionation and Blood Product Product and Services

Table 46. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Global Plasma Fractionation and Blood Product Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 48. Global Plasma Fractionation and Blood Product Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 49. Market Position of Manufacturers in Plasma Fractionation and Blood Product, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 50. Global Plasma Fractionation and Blood Product Production Capacity by Company, (K Units): 2020 VS 2021

Table 51. Head Office and Plasma Fractionation and Blood Product Production Site of Key Manufacturer

Table 52. Plasma Fractionation and Blood Product New Entrant and Capacity Expansion Plans

Table 53. Plasma Fractionation and Blood Product Mergers & Acquisitions in the Past Five Years

Table 54. Global Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)

Table 55. Global Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)

Table 56. Global Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (USD Million)

Table 57. Global Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (USD Million)

Table 58. Global Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)

Table 59. Global Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)

Table 60. Global Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (USD Million)

Table 61. Global Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (USD Million)

Table 62. Global Plasma Fractionation and Blood Product Price by Type (2017-2022) & (US$/Unit)

Table 63. Global Plasma Fractionation and Blood Product Price by Type (2023-2028) & (US$/Unit)

Table 64. Global Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)

Table 65. Global Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)

Table 66. Global Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (USD Million)

Table 67. Global Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (USD Million)

Table 68. Global Plasma Fractionation and Blood Product Price by Application (2017-2022) & (US$/Unit)

Table 69. Global Plasma Fractionation and Blood Product Price by Application (2023-2028) & (US$/Unit)

Table 70. North America Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)

Table 71. North America Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)

Table 72. North America Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (USD Million)

Table 73. North America Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (USD Million)

Table 74. North America Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)

Table 75. North America Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)

Table 76. North America Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)

Table 77. North America Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)

Table 78. Europe Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)

Table 79. Europe Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)

Table 80. Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (USD Million)

Table 81. Europe Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (USD Million)

Table 82. Europe Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)

Table 83. Europe Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)

Table 84. Europe Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)

Table 85. Europe Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)

Table 86. Asia-Pacific Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)

Table 87. Asia-Pacific Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)

Table 88. Asia-Pacific Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (USD Million)

Table 89. Asia-Pacific Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (USD Million)

Table 90. Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)

Table 91. Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)

Table 92. Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)

Table 93. Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)

Table 94. South America Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)

Table 95. South America Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)

Table 96. South America Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (USD Million)

Table 97. South America Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (USD Million)

Table 98. South America Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)

Table 99. South America Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)

Table 100. South America Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)

Table 101. South America Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)

Table 102. Middle East & Africa Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)

Table 103. Middle East & Africa Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)

Table 104. Middle East & Africa Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (USD Million)

Table 105. Middle East & Africa Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (USD Million)

Table 106. Middle East & Africa Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)

Table 107. Middle East & Africa Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)

Table 108. Middle East & Africa Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)

Table 109. Middle East & Africa Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)

Table 110. Plasma Fractionation and Blood Product Raw Material

Table 111. Key Manufacturers of Plasma Fractionation and Blood Product Raw Materials

Table 112. Direct Channel Pros & Cons

Table 113. Indirect Channel Pros & Cons

Table 114. Plasma Fractionation and Blood Product Typical Distributors

Table 115. Plasma Fractionation and Blood Product Typical Customers

List of Figures

Figure 1. Plasma Fractionation and Blood Product Picture

Figure 2. Global Plasma Fractionation and Blood Product Revenue Market Share by Type in 2021

Figure 3. Coagulation Factor

Figure 4. Immune Globulin

Figure 5. Albumin

Figure 6. Other

Figure 7. Global Plasma Fractionation and Blood Product Revenue Market Share by Application in 2021

Figure 8. Immunology

Figure 9. Hematology

Figure 10. Other

Figure 11. Global Plasma Fractionation and Blood Product Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 12. Global Plasma Fractionation and Blood Product Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Plasma Fractionation and Blood Product Sales (2017-2028) & (K Units)

Figure 14. Global Plasma Fractionation and Blood Product Price (2017-2028) & (US$/Unit)

Figure 15. Global Plasma Fractionation and Blood Product Production Capacity (2017-2028) & (K Units)

Figure 16. Global Plasma Fractionation and Blood Product Production Capacity by Geographic Region: 2022 VS 2028

Figure 17. Plasma Fractionation and Blood Product Market Drivers

Figure 18. Plasma Fractionation and Blood Product Market Restraints

Figure 19. Plasma Fractionation and Blood Product Market Trends

Figure 20. Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturer in 2021

Figure 21. Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturer in 2021

Figure 22. Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 23. Top 3 Plasma Fractionation and Blood Product Manufacturer (Revenue) Market Share in 2021

Figure 24. Top 6 Plasma Fractionation and Blood Product Manufacturer (Revenue) Market Share in 2021

Figure 25. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2028)

Figure 26. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2028)

Figure 27. North America Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)

Figure 28. Europe Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)

Figure 29. Asia-Pacific Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)

Figure 30. South America Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)

Figure 31. Middle East & Africa Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)

Figure 32. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)

Figure 33. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)

Figure 34. Global Plasma Fractionation and Blood Product Price by Type (2017-2028) & (US$/Unit)

Figure 35. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)

Figure 36. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)

Figure 37. Global Plasma Fractionation and Blood Product Price by Application (2017-2028) & (US$/Unit)

Figure 38. North America Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)

Figure 39. North America Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)

Figure 40. North America Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2028)

Figure 41. North America Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2028)

Figure 42. United States Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Canada Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Mexico Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Europe Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)

Figure 46. Europe Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)

Figure 47. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2028)

Figure 48. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2028)

Figure 49. Germany Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. France Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. United Kingdom Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Russia Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Italy Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2028)

Figure 55. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)

Figure 56. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2028)

Figure 57. Asia-Pacific Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2028)

Figure 58. China Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Japan Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Korea Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. India Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Southeast Asia Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Australia Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South America Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)

Figure 65. South America Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)

Figure 66. South America Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2028)

Figure 67. South America Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)

Figure 71. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)

Figure 72. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2028)

Figure 73. Middle East & Africa Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2028)

Figure 74. Turkey Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Egypt Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. South Africa Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Manufacturing Cost Structure Analysis of Plasma Fractionation and Blood Product in 2021

Figure 79. Manufacturing Process Analysis of Plasma Fractionation and Blood Product

Figure 80. Plasma Fractionation and Blood Product Industrial Chain

Figure 81. Sales Channel: Direct Channel vs Indirect Channel

Figure 82. Methodology

Figure 83. Research Process and Data Source